480 results on '"Paulsen, Frank"'
Search Results
2. Targeted therapies in retinoblastoma: GD2-directed immunotherapy following autologous stem cell transplantation and evaluation of alternative target B7-H3
3. Dummy run for planning of isotoxic dose-escalated radiation therapy for glioblastoma used in the PRIDE trial (NOA-28; ARO-2024-01; AG-NRO-06)
4. Brachytherapy for rhabdomyosarcoma: Survey of international clinical practice and development of guidelines
5. The prognostic role of the immunohistochemical expression of S100 in meningiomas
6. Detailed functional results after bladder-preserving surgery and high-dose-rate brachytherapy in pediatric bladder/prostate rhabdomyosarcoma
7. Automatic AI-based contouring of prostate MRI for online adaptive radiotherapy
8. Dosimetric feasibility analysis and presentation of an isotoxic dose-escalated radiation therapy concept for glioblastoma used in the PRIDE trial (NOA-28; ARO-2022-12)
9. A multi-institutional series of a novel, recurrent TRIM24::MET fusion-driven infant-type hemispheric glioma reveals significant clinico-pathological heterogeneity
10. Potential of pre-operative MRI features in glioblastoma to predict for molecular stem cell subtype and patient overall survival
11. Radiation-Induced DNA Damage in Uveal Melanoma Is Influenced by Dose Delivery and Chromosome 3 Status
12. Dose-escalated radiotherapy with simultaneous integrated boost for bone metastases in selected patients with assumed favourable prognosis
13. On the probability of lymph node negativity in pN0-staged prostate cancer—a theoretically derived rule of thumb for adjuvant needs
14. Online Adaptive MR-Guided Ultrahypofractionated Radiotherapy of Prostate Cancer on a 1.5 T MR-Linac: Clinical Experience and Prospective Evaluation
15. Evolution of a Meningothelial Meningioma: From WHO Grade 1 to Anaplastic Grade 3 with Extracranial Metastasis Including Extensive Liver Metastasis
16. Postoperative complications and oncologic outcomes after multimodal therapy of localized high risk soft tissue sarcoma
17. Radiotherapy planning parameters correlate with changes in the peripheral immune status of patients undergoing curative radiotherapy for localized prostate cancer
18. Sedation practices during high dose rate brachytherapy for children with urogenital and perianal rhabdomyosarcoma
19. The European Particle Therapy Network (EPTN) consensus on the follow-up of adult patients with brain and skull base tumours treated with photon or proton irradiation
20. Toxicity and Efficacy of Local Ablative, Image-guided Radiotherapy in Gallium-68 Prostate-specific Membrane Antigen Targeted Positron Emission Tomography–staged, Castration-sensitive Oligometastatic Prostate Cancer: The OLI-P Phase 2 Clinical Trial
21. App-based assessment of patient-reported outcomes in the Molecular Tumor Board in the Center for Personalized Medicine—(TRACE).
22. Stellenwert des 1,5-T-MR-Linearbeschleunigers für die primäre Therapie des Prostatakarzinoms
23. Hypofractionated preoperative radiotherapy for high risk soft tissue sarcomas in a geriatric patient population
24. Dummy Run for Planning of Isotoxic Dose-Escalated Radiation Therapy for Glioblastoma Used in the Pride Trial (Noa-28; Aro-2024-01; Ag-Nro-06)
25. Update of the EPTN atlas for CT- and MR-based contouring in Neuro-Oncology
26. The potential role of MR-guided adaptive radiotherapy in pediatric oncology: Results from a SIOPE-COG survey
27. Prospective evaluation of probabilistic dose-escalated IMRT in prostate cancer
28. ERGO2: A Prospective, Randomized Trial of Calorie-Restricted Ketogenic Diet and Fasting in Addition to Reirradiation for Malignant Glioma
29. Retrospective analysis of recurrence patterns and clinical outcome of grade II meningiomas following postoperative radiotherapy
30. Multimodal Therapy with Consolidating Haploidentical Stem Cell Transplantation and Dinutuximab Beta for Patients with High-Risk Neuroblastoma and Central Nervous System Relapse
31. Neurocognitive functioning and health-related quality of life in adult medulloblastoma patients: long-term outcomes of the NOA-07 study
32. Immunosuppressive Total Nodal Irradiation–Based Reconditioning Regimens After Graft Rejection or Graft Failure in Pediatric Patients Treated With Myeloablative Allogeneic Hematopoietic Cell Transplantation
33. Increasing Patient Safety and Treatment Quality by Using Intraoperative MRI for Organ-Preserving Tumor Resection and High-Dose Rate Brachytherapy in Children with Bladder/Prostate and Perianal Rhabdomyosarcoma
34. Radiation dose constraints for organs at risk in neuro-oncology; the European Particle Therapy Network consensus
35. The EPTN consensus-based atlas for CT- and MR-based contouring in neuro-oncology
36. Independent validation of a new reirradiation risk score (RRRS) for glioma patients predicting post-recurrence survival: A multicenter DKTK/ROG analysis
37. Correction to: Retrospective analysis of fractionated intensity-modulated radiotherapy (IMRT) in the interdisciplinary management of primary optic nerve sheath meningiomas
38. Prognostic value of dynamic hypoxia PET in head and neck cancer: Results from a planned interim analysis of a randomized phase II hypoxia-image guided dose escalation trial
39. Automatic AI-based contouring of prostate MRI for online adaptive radiotherapy
40. Retrospective analysis of fractionated intensity-modulated radiotherapy (IMRT) in the interdisciplinary management of primary optic nerve sheath meningiomas
41. Conservative surgery with combined high dose rate brachytherapy for patients suffering from genitourinary and perianal rhabdomyosarcoma
42. Clinical outcome of biomarker-guided therapies in adult patients with tumors of the nervous system
43. Nodal Clearance Rate and Long-Term Efficacy of Individualized Sentinel Node–Based Pelvic Intensity Modulated Radiation Therapy for High-Risk Prostate Cancer
44. Integrative assessment of brain and bone invasion in meningioma patients
45. External validation of a prognostic model estimating the survival of patients with recurrent high-grade gliomas after reirradiation
46. QOL-23. TOWARDS PATIENT-REPORTED OUTCOME ASSESSMENT IN THE MOLECULAR TUMOR BOARD – CANCER PATIENTS UNDER TARGETED THERAPY: APP-BASED ASSESSMENT OF PATIENT-REPORTED OUTCOMES (TRACE)
47. First Experience and Prospective Evaluation on Feasibility and Acute Toxicity of Online Adaptive Radiotherapy of the Prostate Bed as Salvage Treatment in Patients with Biochemically Recurrent Prostate Cancer on a 1.5T MR-Linac
48. Postoperative complications and oncologic outcomes after multimodal therapy of localized high risk soft tissue sarcoma
49. Detailed functional results after bladder-preserving surgery and high-dose-rate brachytherapy in pediatric bladder/prostate rhabdomyosarcoma
50. The prognostic role of the immunohistochemical expression of S100 in meningiomas
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.